[Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors]

Pharm Unserer Zeit. 2010 May;39(3):217-27. doi: 10.1002/pauz.201000369.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Azacitidine / analogs & derivatives
  • Azacitidine / therapeutic use
  • DNA Methylation / drug effects
  • DNA Modification Methylases / antagonists & inhibitors*
  • Decitabine
  • Enzyme Inhibitors / therapeutic use*
  • Epigenesis, Genetic*
  • Humans
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics*

Substances

  • Enzyme Inhibitors
  • Decitabine
  • DNA Modification Methylases
  • Azacitidine